The consolidated Dorris Neuroscience Center was dedicated at Scripps Research Institute
On May 25, 2010, the consolidated Dorris Neuroscience Center was dedicated at the Scripps Research Institute. The new…
-
-
Lawrence Livermore National Laboratory announced Lawrence Livermore Microbial Detection Array
On May 7, 2010, Lawrence Livermore National Laboratory (LLNL) biologists and informatics experts announced the Lawrence Livermore Microbial…
-
Stanford researchers for the first time used a healthy person’s complete genome sequence to predict risk for dozens of diseases
On Apr. 29, 2010, Stanford University of researchers announced they had have used a healthy person’s complete genome…
-
Genentech opened its Hillsboro facility
On Apr. 10, 2010, Genentech opened its $400 million manufacturing center in Hillsboro, Oregon. The 75-acre property campus…
-
Stanford scientists transformed mouse skin cells directly into functional nerve cells with the application of just three genes
On Jan. 27, 2010, scientists at the Stanford University School of Medicine announced they had succeeded in the…
-
FDA Approves Tocilizumab for Treatment of Rheumatoid Arthritis
On Jan. 11, 2010, the U.S. Food and Drug Administration (FDA) approved Genentech’s tocilizumab (Actemra) for the treatment…
-
Carol W. Greider won a share of the Nobel Prize in Physiology or Medicine 2009 for discovering how chromosomes are protected by telomeres
On Oct. 5, 2009, Carol W. Greider won a share of the Nobel Prize in Physiology or Medicine…
-
Phase III results for first HIV/AIDS (Aidsvax) vaccine reported
On Sept. 24, 2009, the second Phase III HIV-1 vaccine trial, also known as RV144, that began in…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | NIH | Therapeutics
CDC began a complex and multi-faceted response to the H1N1 pandemic
On Apr. 15, 2009, infection with the new influenza A virus (then referred to as ‘swine origin influenza…
-
USC purchased Norris Cancer Hospital and University Hospital (now Keck Hospital) from Tenet Healthcare
On Apr. 1, 2009, the University of Southern California (USC) announced they had completed the purchase of Norris…
-
Roche completed it’s acquisition of Genentech for $46.8 billion
On Mar. 26, 2009, Roche completed its acquisition of Genentech for $46.8 billion pursuant to a short-form merger…
-
Stanford researchers discovered the first human bladder cancer stem cell
On Aug. 3, 2009, Researchers at Stanford’s School of Medicine announced they had identified the first human bladder…
-
Stanford researchers developed a test that reduced the risks in testing for chromosomal disorders such as Down syndrome
On Oct. 6, 2008, Stanford researchers developed a test that reduced the risks in testing for chromosomal disorders…
-
Biotechnology | Disease | Medicine | Oncology | Therapeutics
Stanford researchers discovered a molecule that kills kidney cancer cells
On Jul. 8, 2008, Stanford researchers announced discovered a molecule that kills kidney cancer cells. Ideally, the researchers…
-
The Priestley Medal was awarded to Gabor A Somorjai
On Apr. 2, 2008, the American Chemical Society awarded the Priestley Medal to Gabor A. Somorjai “to recognize…
-
New imaging tool can ‘see’ internal body details 1,000X smaller
Apr. 1, 2008, a team of researchers from Stanford’s School of Medicine announced they had developed a new…
-
OHSU Cancer Institute received $5 million gift to establish state-of-the-art research laboratories
On Feb. 20, 2008, Lori and Jen-Hsun Huang of Los Altos Hills, California, announced a $5 million gift…
-
Addario Lung Cancer Medical Institute was founded
In 2008, Addario Lung Cancer Medical Institute was founded as a 501c(3) non-profit organization, is a patient-centric, international…
-
The Donna and Benjamin M Rosen Bioengineering Center was established at Caltech
In 2008, The Donna and Benjamin Rosen Bioengineering Center was established to use a variety of mechanisms and…
-
UCSF researchers discovered that B cells orchestrate the inflammation of myelin that causes multiple sclerosis
In 2008, University of California, San Francisco (UCSF) researchers discovered that B cells orchestrate the inflammation of myelin…
-
UCSF Cancer Research Institute renamed as tribute to philanthropist Helen Diller
On Nov. 19, 2007, the University of California at San Francisco Cancer (UCSF) Research Institute was renamed the…
-
BP Energy Biosciences Institute was established
On Nov. 14, 2007, the BP Energy Biosciences Institute was established with a $500 million ten year grant…
-
The Stanford Cancer Institute became a NCI Designated Cancer Center
On Sept. 23, 2007, the Stanford Cancer Institute (SCI) was awarded “cancer center” designation from the National Cancer…
-
Stanford researchers identified pattern of gene expression shared by transplant patients who stay healthy without anti-rejection drugs
On Aug. 20, 2007, researchers from Stanford University announced they had identified a pattern of gene expression shared…
-
Stanford researchers found that stem cells transplanted into the brains of rats and mice navigate toward areas damaged by stroke
O Jun. 4, 2007, researchers from the Stanford University School of Medicine announced they had illuminated the path…
-
Fuel company BP chose UC-Berkeley to develop biofuels
On Feb. 1, 2007, BP announced that it had selected the University of California, Berkeley, in partnership with…
-
Livermore Lab developed pathogen signatures for bioterrorist attack Identification
In 2007, researchers at Livermore National Laboratory announced they had developed candidate signatures for pathogens that might be…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
-
Corus Pharma was acquired by Gilead Sciences for $365 million
On Aug. 11, 2006, Gilead Sciences announced that it had completed its acquisition of Corus Pharma for $365…
-
Genentech drug Lucentisﾙ (ranibizumab injection) was approved
On Jun. 30, 2006, Genentech drug Lucentisﾙ (ranibizumab injection) was approved by the FDA for the treatment of…
